期刊文献+

涎腺腺样囊性癌细胞系中DNA甲基化研究 被引量:2

DNA methylation in salivary adenoid cystic carcinoma cell lines
原文传递
导出
摘要 目的探讨涎腺腺样囊性癌(adenoid cystic carcinoma,ACC)细胞系中抑癌基因甲基化状况及其与 mRNA、蛋白表达之间的关系。方法甲基化特异性 PCR 法检测 ACC 细胞系 ACC-2、ACC-3、ACC-M 中 E-钙黏着蛋白(E-cadherin,E-cad)、p16、RASSF1A、DAPK、MGMT 基因启动子区的甲基化状况。应用 RT-PCR 方法和免疫组织化学方法检测 E-cad、p16在 mRNA 和蛋白水平的表达。结果 3个 ACC 细胞系中均检测到 E-cad、p16基因的甲基化,而没有 RASSF1A、DAPK、MGMT 基因的甲基化;mRNA 和蛋白水平均未检测到 E-cad 的表达,均检测到 p16的表达。结论 ACC 细胞系中,E-cad、p16基因启动子区的甲基化是常见事件,甲基化可能是 E-cad 基因失活的主要机制之一。 Objective To investigate the promoter methylation status of tumor supressor gene and the relationship between promoter methylation and mRNA, protein expression of tumor suppressor gene in salivary adenoid cystic carcinoma (ACC) cell lines. Methods Promoter methylation status of E-cad, p16, RASSF1A, DAPK, and MGMT was determined by methylation-specific polymerase chain reaction (MSP) in ACC cell lines,ACC-2 ,ACC-3 ,and ACC-M. E-cad, p16 protein and mRNA expression was also examined by IHC and RT-PCR in 3 ACC cell lines. Results All the three salivary ACC cell lines exhibited E-cad, p16 promoter methylation, but no methylation of RASSF1A, DAPK, and MGMT was found. There was p16 protein and mRNA expression but no E-cad expression in 3 ACC cell lines. Conclusions The results suggest that in ACC cell lines, promoter methylation of E-cad, p16 is a common event, and promoter methylation may be one of the major mechanism for inactivation of E-cad.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2007年第3期135-139,共5页 Chinese Journal of Stomatology
基金 国家自然科学基金(30572054) 上海市科学技术委员会科研计划项目(04JC14091)
关键词 涎腺 腺样囊性 DNA甲基化 Salivary Carcinoma, adenoid cystic DNA Methylation
  • 相关文献

参考文献18

  • 1Li J, Wang BY, Nelson M, et al. Salivary adenocarcinoma, not otherwise specified: a collection of orphans. Arch Pathol Lab Med, 204,128(12):1385-1394.
  • 2Spiro RH, Huvos AG, Strong EW. Adenoid cystic carcinoma: factors influencing survival. Am J Surg, 1979,138(4):579-583.
  • 3Kim KH, Sung MW, Chung PS, et al. Adenoid cystic carcinoma of the head and neck, Arch Otolaryngol Head Neck Surg, 1994,120(7):721-726.
  • 4Sung MW, Kim KH, Kim JW, et al. Clinicopathologic predictors and impaet of distant metastasis from adenoid cystic careinoma of head and neck. Arch Otolaryngol Head Ncek Surg, 2003,129(11):1193-1197.
  • 5Attwood JT, Yung RL, Richardson BC. DNA methylation and the regulation of gene transcription. Cell Mol Life Sci, 2002,59(2):241-257.
  • 6Soria JC, Rodriguez M, Liu DD, et al. Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. Cancer Res, 2002,62:351-355.
  • 7Wang J, Lee JJ, Wang L, et al. Value of p16INK4a and RASSF1A promoter hypermethylation in prognosis of patients with resectable non-small cell lung cancer. Clin Cancer Res, 2004,10(18 Pt 1):6119-6125.
  • 8Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A, 1996,93(8):9821-9826.
  • 9Nakayama S, Sasaki A, Mese H, et al. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer, 2001,93(5):667-673.
  • 10Maeta Y, Shiota G, Okano J, et al. Effect of promoter methylation of the p16 gene on phosphorylation of retinoblastoma gene product and growth of hepatocellular carcinoma cells.Tumour Biol, 2005,26(6) :300-305.

二级参考文献10

  • 1Herman JG,Graff JR,Myohanen S,et al. Methylation-specific PCR: A novel PCR assay for methylation status of CpG island[J]. Proc Natl Acad Sci USA,1996,93(18):9821-9826.
  • 2Mirella GZ,Christina MB,Allen SY,et al. Methylation of 5'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing[J].Cancer Res,1995,55(20):4531-4535.
  • 3Minoru T,Coty H,Nito A,et al.Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification[J].Cancer Res,1999,59(9):2307-2312.
  • 4Montserrat SC,Manel E,Li W,et al.Gene promoter hypermethylation in tumors and serum of head and neck cancer patients[J].Cancer Res,2000,60(4):892-895.
  • 5Lin SC,Chang KW,Chang CS,et al.Alterations of p16/MTS1 gene in oral squamous cell carcinomas from Taiwan Residents[J].J Oral Pathol Med,2000,29(4):159-163.
  • 6Hasegawa M,Nelson HH,Peters E,et al.Patterns of gene promoter methylation in squamous cell cancer of the head and neck[J].Oncogene,2002,21(37):4231-4236.
  • 7Tripathi Bhar A,Banerjee S,Chunder N,et al.Differential alterations of the genes in the CDKN2A-CCND1-CDK4-RB1 pathway are associated with the development of head and neck squamous cell carcinoma in Indian patients[J].J Cancer Res Clin Oncol,2003,129(11):642-650.
  • 8Esteller M,Corn PG,Baylin SB,et al.A gene hypermethylation profile of human cancer[J].Cancer Res,2001,61(8):3225-3229.
  • 9史宏男,周正炎,顾云峰.涎腺腺样囊性癌细胞株p16基因缺失、突变及表达意义[J].口腔颌面外科杂志,2001,11(2):111-113. 被引量:3
  • 10王文霞,孙善珍,杨丕山,马伯龙,龙彦.多肿瘤抑制基因1在口腔黏膜癌前病变和鳞癌中的变异[J].中华口腔医学杂志,2003,38(5):361-363. 被引量:2

共引文献6

同被引文献22

  • 1刘宏伟,胡碧琼,曹采方.口腔白斑和鳞癌中p16基因甲基化的研究[J].中华口腔医学杂志,2005,40(2):94-97. 被引量:10
  • 2Zhang CY, Mao L, Li L, et al. Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma[J]. Cancer, 2007, 110(1): 87-95.
  • 3Li J, EI-Naggar A, Mao L. Promoter methylation of p16INK4a, RASSF1A, and DAPK is frequent in salivary adenoid cystic carcinoma[J]. Cancer, 2005, 104(4): 771-776.
  • 4Zhang Z, Sun D, Van do N, et al. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma[J]. Int J Cancer, 2007, 120(1): 32-38.
  • 5Sato N, Parker AR, Fukushima N, et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma[J]. Oncogene, 2005, 24(5): 850-858.
  • 6Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma[J]. Proc Nat1 Acad Sci USA, 1998, 95(12): 6870-6875.
  • 7Livak K J, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method[J]. Methods, 2001, 25(4): 402-408.
  • 8Sun D, Zhang Z, Van do N, et al. Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker[J]. Oral Oncol, 2007, 43(1): 82-87.
  • 9Kim JS, Han J, Shim YM, et al. Aberrant methylation of H- cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma[J]. Cancer, 2005, 104(9): 1825-1833.
  • 10Jin Z, Cheng Y, Olaru A, et al. Promoter hypemlethylation of CDH13 is a common, early event in human esophageal adenocareinogenesis and con'elates with clinical risk factors[J]. Int J Cancer, 2008, 123(10): 2331-2336.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部